| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |